SEC Form 4 · accession 0001408474-16-000003
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
LEE F Allen M.D. Ph.D.
Officer — Chief Medical Officer
Period of report
Apr 15, 2016
Accepted (ET)
Apr 19, 2016 · 12:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $10.97 | Apr 15, 2016 | A | 16,628 | A | — | Apr 14, 2026 | Common Stock | 16,628 | 16,628 | D |
Explanation of responses
- F1This option was granted on April 15, 2016 and vests as to 25% of the shares underlying this option on January 19, 2017, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning January 19, 2017.